ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
+28.33%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$131M
AUM Growth
+$131M
(+43%)
Cap. Flow
+$19.3M
Cap. Flow
% of AUM
14.79%
Top 10 Holdings %
Top 10 Hldgs %
60.52%
Holding
43
New
14
Increased
9
Reduced
9
Closed
11
Top Buys
Top Sells
| 1 |
Baxter International
BAX
|
$6.15M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$4.85M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$4.62M |
| 4 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$3.41M |
| 5 |
Twist Bioscience
TWST
|
$3.21M |
Sector Composition
| 1 | Healthcare | 87.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMY.RT
1
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $12.7M | 9.76% | 3,558,046 +1,173,559 | +49% | +$4.2M |
|
|
ARNA
2
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $10.9M | 8.34% | 172,896 -76,970 | -31% | -$4.85M |
|
|
GBT
3
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.8M | 8.29% | 171,316 +84,739 | +98% | +$5.35M |
|
|
SAGE
4
DELISTED
Sage Therapeutics
SAGE
| $8.2M | 6.28% | +197,249 | New | +$8.2M |
|
5
Guardant Health
GH
$8.41B
| $7.79M | 5.97% | 96,039 +19,601 | +26% | +$1.59M |
|
6
Ascendis Pharma
ASND
$11.8B
| $7.04M | 5.39% | 47,599 +19,442 | +69% | +$2.88M |
|
|
NSTG
7
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.45M | 4.94% | 219,577 +145,076 | +195% | +$4.26M |
|
|
MNTA
8
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.3M | 4.06% | 159,197 +76,110 | +92% | +$2.53M |
|
9
Centene
CNC
$14.3B
| $4.92M | 3.77% | 77,402 +61,084 | +374% | +$3.88M |
|
10
Cytokinetics
CYTK
$4.23B
| $4.86M | 3.72% | 206,086 +1,835 | +0.9% | +$43.2K |
|
11
10x Genomics
TXG
$1.74B
| $4.54M | 3.48% | 50,819 +26,216 | +107% | +$2.34M |
|
|
AVDL
12
Avadel Pharmaceuticals
AVDL
$1.43B
| $4.31M | 3.3% | +533,632 | New | +$4.31M |
|
13
UnitedHealth
UNH
$281B
| $3.81M | 2.92% | 12,904 -2,907 | -18% | -$857K |
|
14
Fate Therapeutics
FATE
$120M
| $3.75M | 2.87% | 109,165 -10,938 | -9% | -$375K |
|
15
PTC Therapeutics
PTCT
$3.92B
| $3.74M | 2.87% | 73,708 -26,762 | -27% | -$1.36M |
|
|
ATRS
16
DELISTED
Antares Pharma, Inc.
ATRS
| $3.57M | 2.74% | +1,299,202 | New | +$3.57M |
|
17
Amicus Therapeutics
FOLD
$2.34B
| $3.54M | 2.71% | 234,753 -83,399 | -26% | -$1.26M |
|
18
Bio-Rad Laboratories Class A
BIO
$8.06B
| $2.91M | 2.23% | 6,434 -6,242 | -49% | -$2.82M |
|
19
BioNTech
BNTX
$24B
| $2.58M | 1.98% | +38,626 | New | +$2.58M |
|
|
20
Twist Bioscience
TWST
$1.63B
| $2.42M | 1.85% | 53,344 -70,776 | -57% | -$3.21M |
|
21
Leap Therapeutics
LPTX
$12M
| $1.88M | 1.44% | +900,733 | New | +$1.88M |
|
|
AIMT
22
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $1.68M | 1.29% | +100,544 | New | +$1.68M |
|
23
Dianthus Therapeutics
DNTH
$759M
| $1.59M | 1.21% | +211,063 | New | +$1.59M |
|
|
BLUE
24
DELISTED
bluebird bio
BLUE
| $1.53M | 1.17% | +25,000 | New | +$1.53M |
|
|
MRNS
25
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.49M | 1.14% | 586,243 -269,075 | -31% | -$683K |
|